NFE2L2 and metabolic dysfunction-associated steatohepatitis: Accumulating evidence suggests that two regulators of oxidative stress defense and inflammation, Nrf2 and AMPK, play a pivotal role in hepatic inflammation and lipid metabolism and the progression of NASH.